Embecta Corp. (NASDAQ:EMBC) Stock Position Raised by Barclays PLC

Barclays PLC lifted its holdings in shares of Embecta Corp. (NASDAQ:EMBC - Free Report) by 41.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 97,930 shares of the company's stock after acquiring an additional 28,523 shares during the quarter. Barclays PLC owned 0.17% of Embecta worth $1,381,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. Quarry LP acquired a new stake in Embecta in the third quarter valued at $30,000. Copeland Capital Management LLC acquired a new stake in shares of Embecta in the 3rd quarter valued at about $43,000. Iat Reinsurance Co. LTD. bought a new position in shares of Embecta during the second quarter worth about $50,000. Canada Pension Plan Investment Board acquired a new position in Embecta in the second quarter worth about $140,000. Finally, CWM LLC increased its holdings in Embecta by 11.3% in the third quarter. CWM LLC now owns 10,102 shares of the company's stock valued at $142,000 after buying an additional 1,023 shares during the last quarter. Institutional investors and hedge funds own 93.83% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Morgan Stanley upgraded Embecta from an "underweight" rating to an "equal weight" rating and lifted their target price for the stock from $13.00 to $20.00 in a research report on Monday, December 2nd. BTIG Research raised shares of Embecta from a "neutral" rating to a "buy" rating and set a $26.00 price objective for the company in a report on Wednesday, November 27th.

Embecta Stock Down 0.6 %

EMBC stock traded down $0.13 during midday trading on Friday, reaching $20.70. The company had a trading volume of 352,095 shares, compared to its average volume of 412,967. The firm has a market capitalization of $1.20 billion, a PE ratio of 15.33, a P/E/G ratio of 1.08 and a beta of 1.25. The stock has a 50 day moving average price of $17.22 and a 200 day moving average price of $15.18. Embecta Corp. has a fifty-two week low of $9.93 and a fifty-two week high of $21.48.

Embecta (NASDAQ:EMBC - Get Free Report) last posted its earnings results on Tuesday, November 26th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.40 by $0.05. The firm had revenue of $286.10 million during the quarter, compared to analysts' expectations of $276.97 million. Embecta had a net margin of 6.97% and a negative return on equity of 18.54%. Embecta's quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.59 EPS. Research analysts predict that Embecta Corp. will post 2.84 EPS for the current year.

Embecta Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Friday, December 6th were issued a $0.15 dividend. The ex-dividend date of this dividend was Friday, December 6th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.90%. Embecta's payout ratio is currently 44.44%.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.